Yep, that is the narratvive being pushed by those promoting stocks like Avita, ARX and MSB...
The other view is that Polynovo management CHOOSE to reinvest the potential profits in the business to expand it, until such time as growth slows. While Swami was keen to develop other areas like DFU, Breast/Hernia products I think to a certain extent it has currently evolved into simply keeping up with demand from customers for the existing product which has so many applications as it is. It's a thriving business.
PNV Media Thread, page-3028
-
- There are more pages in this discussion • 191 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
0.020(0.78%) |
Mkt cap ! $1.780B | |||
| Open | High | Low | Value | Volume |
| $2.61 | $2.63 | $2.56 | $2.465M | 952.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10700 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 24502 | 5 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |